Pratt D S, Schwartz M I, May J J, Dreisin R B
Thorax. 1979 Oct;34(5):587-93. doi: 10.1136/thx.34.5.587.
We sought to explore immunological factors in patients who died with rapidly fatal fibrosing lung diseases (Hamman-Rich syndrome). A retrospective review of cases of interstitial lung disease showed 12 recent deaths from Hamman-Rich syndrome. The mean age was 62, men outnumbering women 3 : 1. Five patients had proved collagen vascular disease (rheumatoid arthritis three, lupus two). Four others had a history of allergic disorders, syphilis, chronic eosinophilia, or hypersensitivity reactions. One patient showed disappearance of immunofluorescence as fibrosis advanced, which has not previously been reported. The study suggests a possible aetiological link between disorders of immunity and Hamman-Rich syndrome. The evidence also supports the notion that Hamman-Rich syndrome is an accelerated variant of the more indolent interstitial pneumonias.
我们试图探究死于快速致死性肺纤维化疾病(Hamman-Rich综合征)患者的免疫因素。一项间质性肺疾病病例回顾性研究显示,近期有12例死于Hamman-Rich综合征。平均年龄为62岁,男性人数是女性的3倍。5例患者已确诊为胶原血管病(类风湿关节炎3例,狼疮2例)。另外4例有过敏症、梅毒、慢性嗜酸性粒细胞增多症或过敏反应病史。1例患者随着纤维化进展免疫荧光消失,此前未见相关报道。该研究提示免疫紊乱与Hamman-Rich综合征之间可能存在病因学联系。证据还支持Hamman-Rich综合征是较隐匿性间质性肺炎的一种加速型变体这一观点。